Clinical Challenges

A Broken System of Addiction Treatment Requires Reimagining Recovery
Despite documented efficacy, adoption of medication-assisted treatment among providers remains slow across the U.S., largely because of a fractured treatment system.
Costs, Lack of Access Deter Americans from Seeking Mental Healthcare, Despite Stress of Current Events
While 85% of Americans surveyed for a recent poll said they rate their mental health status positively, concerns over current events suggest unresolved tensions looming below the surface for many.
Clinicians Prescribing Buprenorphine Far Below Limits of Waivers
Half of clinicians who are waivered to prescribe buprenorphine for the treatment of opioid use disorder have actually done so, and a majority are prescribing the medication for a number of patients that is well below the limit for which they are waivered, according to a new study.
Rates of Anxiety, Depressive Disorders Soar Amid Pandemic
The American Mental Health Counselors Association estimated that 41% of Americans are experiencing a mental illness, such as general anxiety disorder or major depressive disorder, a dramatic rise from pre-pandemic levels that has been spurred by COVID-19, racial tensions and economic calamity.
Opioid Use Linked to Hearing Loss
Opioid use—particularly heroin—has been linked with hearing loss, according to a new study published in the Journal of Medical Toxicology.
Panel: Isolation, Staff Safety and Licensing Among Issues Being Navigated During Pandemic
Concerns over patient isolation, staff safety and licensing reciprocity between states as a means to address a shortage of care providers during a crisis were among the COVID-19-related topics discussed by a panel of industry leaders during a Friday morning session at the virtual National Conference on Addiction Disorders.
Overdose Deaths on the Rise Again Amid COVID-19
Fatal overdoses reported between January and April are up 11.4% compared to last year, and nonfatal overdoses are up 18.6%, with a spike that has coincided with the onset of the COVID-19 pandemic, according to data from ONDCP’s Overdose Data Mapping Application Program.
In This Challenging Time, How Well Do You Test Out?
The coronavirus (COVID-19) pandemic provides a rare opportunity to take stock of our souls or, in psychological terms, our character.
Rx Summit Spotlight: Relatable Messaging Reduces Stigma
Jodi Maiolo, MPH, CPH, and Shanen Wright will discuss a campaign to reduce stigma in Appalachia that they worked on and how some of their takeaways can be used to create more effective messaging in other communities.
Providers Prepare as Coronavirus Spreads
As the number of coronavirus cases climbs above 24,000, addiction treatment and behavioral healthcare providers gather information and review protocols for protecting vulnerable patients.
NCAD West: Digital Therapeutics Reduce Burden on Providers, Improve Efficiency
Stigma, lack of coverage and inadequate training for physicians are creating barriers to treatment for SUD, but digital therapeutics are emerging as an effective complement to boost traditional treatment, according to Smita Das, MD, PhD, MPH, and Mario San Bartolome, MD, MBA, MRO, FASAM.

Videos

Dr. Robert Rymowicz Discusses Food Addiction and Treatment Strategies
In this video, Robert Rymowicz, DO, of the Rutgers New Jersey Medical School, discusses food addiction, how highly processed foods affect the brain, and treatment strategies.
WestBridge Shares Their Perspective When Treating Dual Diagnosis
Best Practices in the Treatment of Co-Occurring Disorders
Back to Top